Valeo Financial Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,595
| Closed | -$62.1K | – | 726 |
|
|
2024
Q4 | $62.1K | Buy |
+9,595
| New | +$62.1K | ﹤0.01% | 676 |
|
|
2021
Q2 | – | Sell |
-466
| Closed | -$63K | – | 1748 |
|
|
2021
Q1 | $63K | Hold |
466
| – | – | ﹤0.01% | 746 |
|
|
2020
Q4 | $66K | Buy |
466
+250
| +116% | +$35.4K | ﹤0.01% | 675 |
|
|
2020
Q3 | $24K | Sell |
216
-84
| -28% | -$9.33K | ﹤0.01% | 850 |
|
|
2020
Q2 | $34K | Buy |
300
+223
| +290% | +$25.3K | ﹤0.01% | 829 |
|
|
2020
Q1 | $6K | Buy |
+77
| New | +$6K | ﹤0.01% | 1220 |
|
|
2019
Q3 | – | Sell |
-300
| Closed | -$26K | – | 1677 |
|
|
2019
Q2 | $26K | Sell |
300
-1,225
| -80% | -$106K | ﹤0.01% | 775 |
|
|
2019
Q1 | $138K | Hold |
1,525
| – | – | 0.02% | 353 |
|
|
2018
Q4 | $109K | Hold |
1,525
| – | – | 0.02% | 356 |
|
|
2018
Q3 | $120K | Hold |
1,525
| – | – | 0.02% | 359 |
|
|
2018
Q2 | $144K | Buy |
1,525
+950
| +165% | +$89.7K | 0.02% | 340 |
|
|
2018
Q1 | $50K | Sell |
575
-625
| -52% | -$54.3K | 0.01% | 488 |
|
|
2017
Q4 | $102K | Buy |
+1,200
| New | +$102K | 0.02% | 338 |
|